Clinical Trial

BMI Stratified Management Based on Meridian-Lymph Axis Theory for Lower Extremity Lymphedema After Gynecologic Cancer Surgery

Study acronym: MLA-BMI-LLE
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study aims to investigate the impact of a BMI-stratified intervention program based on the meridian-lymphatic axis theory on the incidence of lower extremity lymphedema in postoperative patients with gynecological malignant tumors at 1 month, 3 months, and 6 months, and to validate the precision and effectiveness of this program compared to traditional CDT. Primary objectives: to evaluate the effects of this program on reducing the incidence of lymphedema, alleviating lymphedema-related symptoms (assessed via GCLQ score), improving patients' quality of life (assessed via LLQoL score), and enhancing patients' self-management behaviors.
Trial Details
NCT Number NCT07374835
Lead Sponsor Hong Zhang
Conditions Lower Extremity Lymphedema After Gynecologic Cancer Surgery
Enrollment 60 participants
Start Date 2025-10-09
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-29